FAQ/Help |
Calendar |
Search |
Today's Posts |
04-18-2018, 09:58 PM | #1 | ||
|
|||
Member
|
"Preliminary results from the first study of BIIB054 in patients with [Parkinson's] shows a favorable [pharmacokinetics], safety and tolerability profiles, providing rationale for further clinical development,"
#AAN2 18 Biogen's BIIB 54 Posts Positive Data in Parkinson's Trial |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||